STERIS plc Operating Expenses
STERIS plc (STE) reported Operating Expenses of $398.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-07
- STERIS plc operating expenses for the quarter ending 2026-06-30 was $398.30M, a 4.27% increase year-over-year.
- STERIS plc operating expenses for the quarter ending 2026-03-31 was $380.30M, a 10.52% decline year-over-year.
- STERIS plc operating expenses for the quarter ending 2025-12-31 was $382.30M, a 4.74% increase year-over-year.
- STERIS plc operating expenses for the quarter ending 2025-09-30 was $380.10M, a 5.85% increase year-over-year.
- STERIS plc operating expenses for fiscal 2026 was $1.52B, a 0.74% decline from fiscal 2025.
- STERIS plc operating expenses for fiscal 2025 was $1.54B, a 11.15% increase from fiscal 2024.
- STERIS plc operating expenses for fiscal 2024 was $1.38B, a 16.17% increase from fiscal 2023.
- STERIS plc operating expenses for fiscal 2023 was $1.19B, a 15.34% decline from fiscal 2022.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $398.30M 10-Q · filed 2026-08-07 | $778.60M derived: sum of 2 quarters · filed 2026-08-07 | $1.16B derived: sum of 3 quarters · filed 2026-08-07 | $1.54B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $380.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $762.60M derived: sum of 2 quarters · filed 2026-05-29 | $1.14B derived: sum of 3 quarters · filed 2026-05-29 | $1.52B 10-K · filed 2026-05-29 | ||||
| 2025-12-31 | $382.30M 10-Q · filed 2026-02-06 | $762.40M derived: sum of 2 quarters · filed 2026-02-06 | $1.14B 10-Q · filed 2026-02-06 | $1.57B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-09-30 | $380.10M 10-Q · filed 2025-11-06 | $762.10M 10-Q · filed 2025-11-06 | $1.19B derived: sum of 3 quarters · filed 2026-08-07 | $1.55B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $382.00M 10-Q · filed 2026-08-07 | $807.00M derived: sum of 2 quarters · filed 2026-08-07 | $1.17B derived: sum of 3 quarters · filed 2026-08-07 | $1.53B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $425.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $790.00M derived: sum of 2 quarters · filed 2026-05-29 | $1.15B derived: sum of 3 quarters · filed 2026-05-29 | $1.54B 10-K · filed 2026-05-29 | $1.54B 10-K · filed 2025-05-29 | |||
| 2024-12-31 | $365.00M 10-Q · filed 2026-02-06 | $365.04M 10-Q · filed 2025-02-07 | $724.10M derived: sum of 2 quarters · filed 2026-02-06 | $1.11B 10-Q · filed 2026-02-06 | $1.11B 10-Q · filed 2025-02-07 | $1.47B derived: sum of 4 quarters · filed 2026-05-29 | ||
| 2024-09-30 | $359.10M 10-Q · filed 2025-11-06 | $359.13M 10-Q · filed 2024-11-07 | $746.00M 10-Q · filed 2025-11-06 | $746.02M 10-Q · filed 2024-11-07 | $1.11B derived: sum of 3 quarters · filed 2026-05-29 | $1.44B derived: sum of 4 quarters · filed 2026-05-29 | ||
| 2024-06-30 | $386.90M 10-Q · filed 2025-08-07 | $386.90M 10-Q · filed 2024-08-08 | $749.43M derived: sum of 2 quarters · filed 2026-05-29 | $1.08B derived: sum of 3 quarters · filed 2026-05-29 | $1.44B derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-03-31 | $362.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $696.08M derived: sum of 2 quarters · filed 2026-05-29 | $1.05B derived: sum of 3 quarters · filed 2026-05-29 | $1.38B 10-K · filed 2026-05-29 | $1.38B 10-K · filed 2024-05-29 | |||
| 2023-12-31 | $333.56M 10-Q · filed 2025-02-07 | $386.44M 10-Q · filed 2024-02-08 | $688.23M derived: sum of 2 quarters · filed 2025-02-07 | $1.02B 10-Q · filed 2025-02-07 | $1.18B 10-Q · filed 2024-02-08 | $680.25M derived: sum of 4 quarters · filed 2025-05-29 | ||
| 2023-09-30 | $354.68M 10-Q · filed 2024-11-07 | $407.67M 10-Q · filed 2023-11-07 | $685.92M 10-Q · filed 2024-11-07 | $792.25M 10-Q · filed 2023-11-07 | $346.70M derived: sum of 3 quarters · filed 2025-05-29 | $677.39M derived: sum of 4 quarters · filed 2025-05-29 | ||
| 2023-06-30 | $331.24M 10-Q · filed 2024-08-08 | $384.58M 10-Q · filed 2023-08-08 | -$7.98M derived: sum of 2 quarters · filed 2025-05-29 | $322.71M derived: sum of 3 quarters · filed 2025-05-29 | $1.16B derived: sum of 4 quarters · filed 2025-05-29 | |||
| 2023-03-31 | -$339.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | -$8.53M derived: sum of 2 quarters · filed 2025-05-29 | $830.22M derived: sum of 3 quarters · filed 2025-05-29 | $1.19B 10-K · filed 2025-05-29 | $1.89B 10-K · filed 2023-05-26 | |||
| 2022-12-31 | $330.69M 10-Q · filed 2024-02-08 | $1.17B derived: sum of 2 quarters · filed 2024-02-08 | $1.53B 10-Q · filed 2024-02-08 | $1.82B derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-09-30 | $838.75M 10-Q · filed 2023-11-07 | $1.20B 10-Q · filed 2023-11-07 | $1.49B derived: sum of 3 quarters · filed 2024-05-29 | $1.83B derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-06-30 | $359.40M 10-Q · filed 2023-08-08 | $653.62M derived: sum of 2 quarters · filed 2024-05-29 | $988.80M derived: sum of 3 quarters · filed 2024-05-29 | $1.35B derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-03-31 | $294.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | $629.39M derived: sum of 2 quarters · filed 2024-05-29 | $993.23M derived: sum of 3 quarters · filed 2024-05-29 | $1.41B 10-K · filed 2024-05-29 | $1.59B 10-K · filed 2022-05-31 | |||
| 2021-12-31 | $335.18M 10-Q · filed 2023-02-08 | $699.02M derived: sum of 2 quarters · filed 2023-02-08 | $1.11B 10-Q · filed 2023-02-08 | $1.35B derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-09-30 | $363.84M 10-Q · filed 2022-11-09 | $775.80M 10-Q · filed 2022-11-09 | $1.01B derived: sum of 3 quarters · filed 2023-05-26 | $1.21B derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-06-30 | $411.96M 10-Q · filed 2022-08-08 | $647.52M derived: sum of 2 quarters · filed 2023-05-26 | $846.35M derived: sum of 3 quarters · filed 2023-05-26 | $1.04B derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-03-31 | $235.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $434.39M derived: sum of 2 quarters · filed 2023-05-26 | $623.16M derived: sum of 3 quarters · filed 2023-05-26 | $794.73M 10-K · filed 2023-05-26 | ||||
| 2020-12-31 | $198.83M 10-Q · filed 2022-02-09 | $387.61M derived: sum of 2 quarters · filed 2022-02-09 | $559.17M 10-Q · filed 2022-02-09 | $765.47M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-09-30 | $188.77M 10-Q · filed 2021-11-08 | $360.34M 10-Q · filed 2021-11-08 | $360.34M 10-Q · filed 2020-11-06 | $566.64M derived: sum of 3 quarters · filed 2022-05-31 | $755.60M derived: sum of 4 quarters · filed 2022-05-31 | |||
| 2020-06-30 | $171.57M 10-Q · filed 2021-08-09 | $377.86M derived: sum of 2 quarters · filed 2022-05-31 | $566.83M derived: sum of 3 quarters · filed 2022-05-31 | $758.76M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-03-31 | $206.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | $395.26M derived: sum of 2 quarters · filed 2022-05-31 | $587.20M derived: sum of 3 quarters · filed 2022-05-31 | $782.95M 10-K · filed 2022-05-31 | ||||
| 2019-12-31 | $188.97M 10-Q · filed 2021-02-09 | $380.90M derived: sum of 2 quarters · filed 2021-02-09 | $576.65M 10-Q · filed 2021-02-09 | $770.49M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-09-30 | $191.93M 10-Q · filed 2020-11-06 | $387.69M 10-Q · filed 2020-11-06 | $581.53M derived: sum of 3 quarters · filed 2021-05-28 | $798.94M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-06-30 | $195.75M 10-Q · filed 2020-08-07 | $389.59M derived: sum of 2 quarters · filed 2021-05-28 | $607.01M derived: sum of 3 quarters · filed 2021-05-28 | $785.09M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-03-31 | $193.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28 | $411.25M derived: sum of 2 quarters · filed 2021-05-28 | $589.34M derived: sum of 3 quarters · filed 2021-05-28 | $763.96M 10-K · filed 2021-05-28 | ||||
| 2018-12-31 | $217.41M 10-Q · filed 2020-02-10 | $395.50M derived: sum of 2 quarters · filed 2020-02-10 | $570.12M 10-Q · filed 2020-02-10 | |||||
| 2018-09-30 | $178.09M 10-Q · filed 2019-11-07 | $352.71M 10-Q · filed 2019-11-07 | ||||||
| 2018-06-30 | $174.63M 10-Q · filed 2019-08-07 | |||||||
| 2018-03-31 | $692.86M 8-K · filed 2021-02-09 | |||||||
| 2017-03-31 | $800.01M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |